Nigeria healthcare worker SARS-CoV-2 serology study: Results from a prospective, longitudinal cohort

Author:

Ojji Dike B.ORCID,Sancilio Amelia,Shedul Gabriel L.ORCID,Orji Ikechukwu A.,Chopra Aashima,Abu Joel,Akor Blessing,Ripiye NanaORCID,Akinlade FunmiORCID,Okoye Douglas,Okpetu EmmanuelORCID,Eze Helen,Odoh Emmanuel,Baldridge Abigail S.ORCID,Tripathi Priya,Abubakar Haruna,Jamda Abubakar M.ORCID,Hirschhorn Lisa R.,McDade Thomas,Huffman Mark D.

Abstract

Healthcare workers, both globally and in Nigeria, have an increased risk for SARS-CoV-2 infection compared with the general population due to higher risk contacts, including occupational exposures. In addition, primary healthcare workers represent an important group for estimating prior infection to SARS-CoV-2 because they work at the first point-of-contact for most patients yet have not been included in prior COVID-19 seroepidemiology research in Nigeria. We sought to evaluate baseline seroprevalence, rates of seroconversion (IgG- to IgG+) and seroreversion (IgG+ to IgG-), change in IgG concentration at 3- and 6-month follow-up, and factors associated with seropositivity. From June 2020 to December 2020, we conducted a longitudinal seroepidemiology study among frontline health care workers in Nigeria using a validated dried blood spot assay. Among 525 participants, mean (SD) age was 39.1 (9.7) years, 61.0% were female, and 45.1% were community health workers. The six-month follow-up rate was 93.5%. Seropositivity rates increased from 31% (95% CI: 27%, 35%) at baseline to 45% (95% CI: 40%, 49%) at 3-month follow-up, and 70% (95% CI: 66%, 74%) at 6-month follow-up. There was a corresponding increase in IgG levels from baseline (median = 0.18 ug/mL) to 3-month (median = 0.35 ug/mL) and 6-month follow-up (median = 0.59 ug/mL, Ptrend < .0001). A minority of participants reported symptoms from February 2020 until baseline (12.2%) or during 3-month (6.6%) or 6-month (7.5%) follow-up. only 1 participant was hospitalized. This study demonstrated high baseline, 3-month and 6-month follow-up prevalence of IgG antibodies to SARS-CoV-2 during the first two waves of the COVID-19 pandemic in Nigeria among a cohort of unvaccinated frontline healthcare workers, including primary healthcare workers despite low symptomatology. These results may have implications in state- and national-level disease pandemic modeling. Trial registration: NCT04158154.

Funder

National Heart, Lung, and Blood Institute

Publisher

Public Library of Science (PLoS)

Reference23 articles.

1. Johns Hopkins Coronavirus Resource Center [Internet]. Available from: https://coronavirus.jhu.edu/map.html. Accessed 18 April 2022.

2. Nigeria responds to COVID-19; first case detected in sub-Saharan Africa;P. Adepoju;Nat Med

3. The first and second waves of the COVID-19 pandemic in Africa: a cross-sectional study;S Salyer;Lancet,2021

4. SARS-CoV-2 infection in Africa: A systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021;H Lewis;medRxiv,2022

5. COVID-19 Household Seroprevalence Surveys [Internet]. Available from: https://ncdc.gov.ng/news/323/ncdc-and-nimr-release-findings-of-covid-19-household-seroprevalence-surveys-in-four-states-of-nigeria. Accessed 18 April 2022.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3